|
Librium is a trademark for chlordiazepoxide.
chlordiazepoxide
Chlordiazepoxide (pronounced [ˈklɔːrˌdaɪəzepˈoksaɪd], marketed under the trade name Librium®) is a sedative/hypnotic drug which is a benzodiazepine derivative. It has a medium to long half life. HistorySee the main article benzodiazepine for the history of Librium. PharmacologyChlordiazepoxide is believed to act on the GABAA receptor, thereby producing inhibitory effects similar to the other benzodiazepines. IndicationsChlordiazepoxide is indicated for the treatment of insomnia, anxiety and panic attacks. It has also been used as a treatment for acute alcohol or opiate withdrawal, as well as relief from Crohn's and ulcerative colitis. DosageChlordiazepoxide is available in dosages of 5mg, 10mg and 25mg. Side effectsCommon side effects of chlordiazepoxide include:
ContraindicationsUse of chlordiazepoxide should be avoided in individuals with the following conditions:
OverdoseAn individual who has consumed too much chlordiazepoxide will display one or more of the following symptoms:
In animal models, the oral LD50 of chlordiazepoxide is 537 mg/kg. Chlordiazepoxide overdose is considered a medical emergency and generally requires the immediate attention of medical personnel. The antidote for an overdose of chlordiazepoxide (or any other benzodiazepine) is flumazenil (Anexate®). Legal statusInternationally, chlordiazepoxide is a Schedule IV drug under the Convention on Psychotropic Substances [1]. Alternative trade names
External linksReferences
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
undefined
undefined
undefined
undefined
|
|||||||||||||||||||||||||||||||||||||||||||||||


